Hernandez Joseph 4
4 · Clarus Therapeutics Holdings, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Hernandez Joseph
Director
Transactions
- Award
Common Stock
2022-06-07+1,922→ 1,243,266 total - Award
Stock Option (Right to Buy)
2022-06-07+4,805→ 4,805 totalExercise: $0.43Exp: 2032-06-06→ Common Stock (4,805 underlying)
Holdings
- 65,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.
- [F2]These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.
- [F3]These shares are held by Blue Water Sponsor LLC (the "Sponsor"). Mr. Joseph Hernandez, a director and former chief executive officer of the registrant, is the managing member of the Sponsor. Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.